Kangfu Medical: Plans to repurchase A-shares worth 100-200 million yuan and cancel them.

Kangfu Medical announced that the company plans to repurchase part of its A shares through centralized bidding trading and cancel them, reducing its registered capital. The repurchase amount shall not be less than 100 million RMB and not exceed 200 million RMB, with a repurchase price not exceeding 69.66 RMB per share. It is estimated that 1.4355 million shares to 2.8711 million shares will be repurchased, accounting for 0.61% to 1.22% of the total share capital. The implementation period is within 12 months from the date of approval of the scheme by the shareholders' meeting. The sources of funds are self-owned funds and a special loan of up to 180 million RMB. There are risks in this repurchase, including creditors' disagreement, stock price exceeding the upper limit, and the occurrence of major events.